Mentice AB (publ) (FRA:MN2)

Germany flag Germany · Delayed Price · Currency is EUR
1.350
+0.010 (0.75%)
At close: Nov 28, 2025
-33.82%
Market Cap38.56M
Revenue (ttm)24.96M
Net Income (ttm)-3.92M
Shares Outn/a
EPS (ttm)-0.14
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volume1
Open1.350
Previous Close1.340
Day's Range1.350 - 1.350
52-Week Range0.800 - 2.310
Betan/a
RSI69.08
Earnings DateFeb 2, 2026

About Mentice AB

Mentice AB (publ), together with its subsidiaries, develops, sells, and markets solutions for training and decision support in the clinical area of interventional angiography in cardiology, neurology, vascular surgery, and radiology. It operates through the Mentice VIST, Physical Sim, and Ankyras segments. The company offers virtual simulation products, including VR simulator platforms; procedural learning models; patient simulator accessories and extensions for endovascular therapies; and Angiosuite integrations, such as the VIST virtual patie... [Read more]

Industry Prepackaged Software
Founded 1998
Employees 131
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol MN2
Full Company Profile

Financial Performance

In 2024, Mentice AB's revenue was 291.81 million, an increase of 6.07% compared to the previous year's 275.12 million. Losses were -18.42 million, 553.9% more than in 2023.

Financial numbers in SEK Financial Statements

News

There is no news available yet.